Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2005
09/14/2005EP1572629A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
09/14/2005EP1572222A1 Use of an extract from the plant argania spinosa
09/14/2005EP1572220A1 Antiviral, anti-infectious and cicatrising properties of extracts of dichrostachys glomerata
09/14/2005EP1572211A1 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines
09/14/2005EP1572183A1 Alpha-2-delta ligand for the treatment of sexual dysfunction
09/14/2005EP1572179A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor
09/14/2005EP1572176A2 Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid
09/14/2005EP1572172A1 Alpha2delta ligands for different pharmaceutical uses
09/14/2005EP1572148A1 Cosmetic composition comprising a metalloproteinase inhibitor and a lipopeptide
09/14/2005EP1572101A2 Disease treatment via antimicrobial peptide inhibitors
09/14/2005EP1572093A2 Improved treatment of cancer with glutamine
09/14/2005EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/14/2005EP1572073A2 Alteration of rab38 function to modulate mammalian pigmentation
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1572066A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
09/14/2005EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
09/14/2005EP1390062A4 Modulators of elastase inhibitor secretion
09/14/2005EP1274446B1 Polysaccharidic esters of n-derivatives of glutamic acid
09/14/2005EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion
09/14/2005EP1140009B1 Absorbent article composition and use thereof for sequestering skin irritants.
09/14/2005EP1073418A4 Aqueous composition comprising active ingredients for the de-pigmentation of the skin
09/14/2005EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/14/2005CN1668758A Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
09/14/2005CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/14/2005CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
09/14/2005CN1668621A Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
09/14/2005CN1668620A 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/14/2005CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
09/14/2005CN1668598A Use of chemotherapeutic agents
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
09/14/2005CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668317A Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
09/14/2005CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
09/14/2005CN1668306A 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-((pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-RET kinase associated diseases
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1666985A Medical use of andrographolidume and its derivatives and analogs
09/14/2005CN1666755A Externally applied medicine for treating white hair and its preparation method
09/14/2005CN1666750A Peach blossom oil and its production process
09/14/2005CN1666737A Application of citric acid solution in preparation of antiphlogistic drug
09/14/2005CN1218940C Nitric oxide synthase inhibitors
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218744C Preparing method of burn and scald treating medicine
09/14/2005CN1218731C Chinese medicine for treating dermatopathy and gynecopathy disease and its preparing process
09/14/2005CN1218729C Xuerongguyugao ointment for healing fracture and its prepn.
09/14/2005CN1218720C Chinese medicine burn paste and its producing method
09/14/2005CN1218717C Medicine for saprophage removing and muscle growing and method for preparing the same
09/13/2005US6943251 Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
09/13/2005US6943197 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
09/13/2005US6943195 Cycloalkenone derivative
09/13/2005US6943190 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis
09/13/2005US6943174 6,5-Fused bicyclic heterocycles
09/13/2005US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders.
09/13/2005US6943146 Control cell proliferation, cell differentiation; culture product
09/13/2005US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
09/13/2005US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C
09/13/2005US6942870 For prevention of photodamage skin, for topical application
09/13/2005US6942852 N-terminal modifications of RANTES and methods of use
09/13/2005CA2371587C Piperidine derivatives useful as ccr5 antagonists
09/13/2005CA2371583C Piperazine derivatives useful as ccr5 antagonists
09/13/2005CA2279276C Arylsulfonylamino hydroxamic acid derivatives
09/13/2005CA2248198C Use of n-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss
09/09/2005WO2005083076A1 Immune stimulant oligonucleotide inducing interferon alpha
09/09/2005WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof
09/09/2005WO2005082905A1 Bicyclic heterocyclic compound
09/09/2005WO2005082889A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082847A1 Bicyclo derivative
09/09/2005WO2005082839A1 Amide compound
09/09/2005WO2005082402A1 Preventive/therapeutic agent for organ fibrosis
09/09/2005WO2005082395A1 Novel hair growth stimulant and anti-alopecia agent
09/09/2005WO2005011725A3 Anti-angiogenetic agent and its use, in particular in cancer treatment
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2846382A1 Iron based compounds for elastogenesis and connective tissue treatment
09/09/2005CA2562871A1 Iron based compounds for elastogenesis and connective tissue treatment
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2556768A1 Piperidinyl targeting compounds that selectively bind integrins
09/08/2005US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc.
09/08/2005US20050197349 Pyrrolo[2,3-D]pyrimidine compounds
09/08/2005US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species
09/08/2005US20050197282 Compositions and methods for treatment of psoriasis
09/08/2005US20050196838 Reduced immunogenicity; increased affinity and avidity; improved cell culturing
09/08/2005US20050196428 Dilute aqueous solution containing epidermal growth factor in gel
09/08/2005US20050196365 Method for improving sensory characteristics of semisolid predominantly anhydrous lipids
09/08/2005DE102004007966A1 Topische Zusammensetzung, enthaltend mindestens ein Aryloxim und Bisabolol Topical composition comprising at least one aryl oxime and bisabolol
09/07/2005EP1571155A1 Peptides and medicinal compositions containing the same
1 ... 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 ... 1065